JD Health International : CLARIFICATION ANNOUNCEMENT PROXY FORM FOR THE 2021 ANNUAL GENERAL MEETING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

JD Health International Inc.

京東健康股份有限公司

(A company incorporated in the Cayman Islands with limited liability)

(Stock Code: 6618)

CLARIFICATION ANNOUNCEMENT

PROXY FORM

FOR THE 2021 ANNUAL GENERAL MEETING

References are made to the notice (the "AGM Notice") of the annual general meeting to be held on June 23, 2021 (the "AGM") and the proxy form for the AGM (the "Proxy Form") published on April 23, 2021 by JD Health International Inc. (the "Company"), among which the date, time and venue of the AGM and the resolutions to be proposed at the AGM for the Company's shareholders' approval were set out.

The Company would like to clarify the numbering of resolutions no. 2(b) and 3 as set out in the Proxy Form should be resolutions no. 3 and 4 respectively.

Save as above, all information and contents stated in the AGM Notice and the Proxy Form are remain unchanged. This clarification announcement is supplemental to and should be read in conjunction with the AGM Notice and the Proxy Form. The Proxy Form which have been dispatched for the purpose of the AGM will remain valid for use for the AGM.

By order of the Board

JD Health International Inc.

Mr. Lijun Xin

Executive Director

Hong Kong, May 10, 2021

As at the date of this announcement, the Board comprises Mr. Lijun Xin as the executive Director, Mr. Richard Qiangdong Liu, Mr. Lei Xu, Ms. Sandy Ran Xu, Ms. Pang Zhang and Mr. Qingqing Yi as non-executive Directors, and Mr. Xingyao Chen, Ms. Ling Li and Dr. Jiyu Zhang as independent non-executive Directors.